Abstract Introduction and purpose Lipodystrophy (LD) syndromes are characterized by the loss of adipose tissue resulting in metabolic complications accelerated atherosclerosis. The systemic concentration adipokine leptin is reduced LD as a result deficiency. A therapeutical option to treat substitution leptin, which improves reduces mortality. However, vascular effects remain largely unknown. H...